|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,555.00 JPY | -3.10% |
|
-0.85% | +12.35% |
| 08-03 | Organo Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 06-05 | Organo Corporation Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
Company Valuation: Organo Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 116,036 | 165,430 | 353,770 | 292,805 | 625,823 | 690,655 | - | - |
| Change | - | 42.57% | 113.85% | -17.23% | 113.73% | 10.36% | - | - |
| Enterprise Value (EV) 1 | 111,466 | 182,891 | 372,593 | 298,611 | 629,170 | 688,652 | 668,912 | 635,826 |
| Change | - | 64.08% | 103.72% | -19.86% | 110.7% | 9.45% | -2.87% | -4.95% |
| P/E | 12.6x | 14.1x | 20.4x | 12.1x | 22x | 22.6x | 19.7x | 18.3x |
| PBR | 1.53x | 1.92x | 3.47x | 2.42x | 4.38x | 4.2x | 3.73x | 3.28x |
| PEG | - | 0.5x | 0.4x | 0.3x | 1.3x | 2.92x | 1.3x | 2.35x |
| Capitalization / Revenue | 1.04x | 1.25x | 2.35x | 1.79x | 3.52x | 3.39x | 3.02x | 2.84x |
| EV / Revenue | 0.99x | 1.38x | 2.48x | 1.83x | 3.54x | 3.38x | 2.93x | 2.61x |
| EV / EBITDA | - | 10.7x | 15.2x | 9.04x | 15.9x | 15.9x | 13x | 11.4x |
| EV / EBIT | 10.3x | 12x | 16.5x | 9.6x | 16.7x | 16.6x | 14.2x | 12.5x |
| EV / FCF | 15.1x | -9.14x | 161x | 16.3x | 65.7x | 25.5x | 23.3x | 20x |
| FCF Yield | 6.64% | -10.9% | 0.62% | 6.13% | 1.52% | 3.93% | 4.3% | 5% |
| Dividend per Share 2 | 40 | 62 | 102 | 160 | 200 | 226.7 | 246.7 | 260 |
| Rate of return | 1.58% | 1.72% | 1.32% | 2.51% | 1.47% | 1.51% | 1.64% | 1.73% |
| EPS 2 | 200.7 | 255.8 | 376.9 | 525.4 | 617.7 | 665.5 | 763.3 | 822.8 |
| Distribution rate | 19.9% | 24.2% | 27.1% | 30.5% | 32.4% | 34.1% | 32.3% | 31.6% |
| Net sales 1 | 112,069 | 132,426 | 150,356 | 163,269 | 177,654 | 203,900 | 228,600 | 243,433 |
| EBITDA 1 | - | 17,036 | 24,554 | 33,045 | 39,629 | 43,200 | 51,650 | 55,700 |
| EBIT 1 | 10,850 | 15,212 | 22,544 | 31,120 | 37,648 | 41,400 | 47,133 | 50,800 |
| Net income 1 | 9,210 | 11,730 | 17,310 | 24,150 | 28,401 | 30,867 | 35,100 | 37,833 |
| Net Debt 1 | -4,570 | 17,461 | 18,823 | 5,806 | 3,347 | -2,003 | -21,743 | -54,829 |
| Reference price 2 | 2,532.50 | 3,605.00 | 7,700.00 | 6,370.00 | 13,610.00 | 15,020.00 | 15,020.00 | 15,020.00 |
| Nbr of stocks (in thousands) | 45,819 | 45,889 | 45,944 | 45,966 | 45,983 | 45,982 | - | - |
| Announcement Date | 12/05/22 | 12/05/23 | 13/05/24 | 13/05/25 | 13/05/26 | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 22.57x | 3.38x | 15.94x | 1.51% | 4.36B | ||
| 25.24x | 3.22x | 17.23x | 1.22% | 11.4B | ||
| 54.06x | 3.38x | 21.32x | - | 4.01B | ||
| 29.63x | - | - | - | 1.38B | ||
| 38.32x | 2.66x | 22.52x | 0.41% | 934M | ||
| Average | 33.96x | 3.16x | 19.25x | 1.05% | 4.42B | |
| Weighted average by Cap. | 30.77x | 3.26x | 17.99x | 1.25% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 6368 Stock
- Valuation Organo Corporation
Select your edition
All financial news and data tailored to specific country editions
















